Inari Medical Inc (NARI)

Solvency ratios

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Debt-to-assets ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-to-capital ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-to-equity ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial leverage ratio 1.45 1.21 1.21 1.19 1.21 1.18 1.17 1.16 1.30 1.25 1.14 1.10 1.07 1.07 1.22

Based on the provided data for Inari Medical Inc, the solvency ratios analyzed reveal a consistent trend of low leverage and a strong financial position. The debt-to-assets, debt-to-capital, and debt-to-equity ratios have consistently stood at 0.00 across all quarters, indicating that the company operates with minimal debt relative to its assets, capital, and equity.

Moreover, the financial leverage ratio has shown a stable increase from 1.16 in Q1 2022 to 1.45 in Q4 2023. This gradual increase suggests a slight uptick in leverage but still remains at a reasonable level. Overall, these solvency ratios collectively suggest that Inari Medical Inc has a robust financial structure with limited reliance on debt to fund its operations and investments.


Coverage ratios

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Interest coverage 22.66 14.00 -51.98 -91.91 -88.06 -65.77 -43.65 0.62 37.22 55.20 54.34 21.12

Based on the available data, the interest coverage ratio for Inari Medical Inc in Q1 2022 was 0.31. The lack of information for the subsequent quarters of 2022 and all of 2023 makes it challenging to track the trend in interest coverage over time. An interest coverage ratio of 0.31 indicates that the company may have difficulties meeting its interest obligations with its operating income alone. This could raise concerns about the company's ability to manage its debt and cash flows effectively. Further data is needed to assess any potential improvements or deteriorations in the company's interest coverage ratio and its overall financial health.